Kari E Sower, NP
Nurse Practitioner · East Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
- Since medical school
- 11 years
- Graduated 2015
Offices
1 location · South County Community Health Center Inc · 20 clinicians in this group
Looking this up.
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Kari E Sower’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Medicaid work
$1,321 in 2020
Medicaid paid $1,321 for 18 billed services this clinician did in 2020, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 18 | $1,321 |
| 2020 | 18 | 1 | 17 | $1,321 |
| 2019 | 17 | 1 | 13 | $988 |
See the largest Medicaid services in earlier years
2019
| Return visit (30+ min) | 17 | $988 |
Drugs they prescribed that Part D paid
$39,512
Pharmacies billed $39,512 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 656) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
601 generic and 55 brand-name prescriptions · $39,512 in drug cost · 15 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 299 | $17,821 | $60 |
| Estradiol (Twice Weekly) | 35 | $4,321 | $123 |
| Progesterone | 86 | $3,741 | $44 |
| Estradiol (Once Weekly) | 31 | $3,378 | $109 |
| Clobetasol Propionate | 26 | $469 | $18 |
See all 9 drugs
| Estradiol | 299 | $17,821 | $60 |
| Estradiol (Twice Weekly) | 35 | $4,321 | $123 |
| Progesterone | 86 | $3,741 | $44 |
| Estradiol (Once Weekly) | 31 | $3,378 | $109 |
| Clobetasol Propionate | 26 | $469 | $18 |
| Valacyclovir | 21 | $379 | $18 |
| Nystatin-Triamcinolone | 23 | $370 | $16 |
| Nystatin | 12 | $94 | $8 |
| Fluconazole | 14 | $56 | $4 |
Year by year
| 2024 | 656 | 269 | 0% (0) | 8% | $39,512 |
| 2023 | 428 | 181 | 0% (0) | 9% | $37,533 |
| 2022 | 343 | 145 | 0% (0) | 10% | $25,965 |
| 2021 | 59 | 44 | 0% (0) | 20% | $5,646 |
| 2020 | 119 | 64 | 23% (27) | 13% | $40,224 |
| 2019 | 129 | 58 | 25% (32) | 12% | $4,356 |
| 2018 | 184 | 72 | 19% (34) | 11% | $8,182 |
| 2017 | 192 | 69 | 15% (29) | None | $7,553 |
| 2016 | 21 | 13 | None | None | $339 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Estradiol | 156 | $14,345 | $92 |
| Estradiol (Twice Weekly) | 18 | $3,233 | $180 |
| Progesterone | 42 | $2,808 | $67 |
| Estradiol (Once Weekly) | 20 | $2,299 | $115 |
| Clobetasol Propionate | 29 | $1,078 | $37 |
| Valacyclovir | 15 | $1,015 | $68 |
| Nystatin-Triamcinolone | 15 | $414 | $28 |
| Norethindrone | 13 | $295 | $23 |
| Paroxetine | 12 | $249 | $21 |
| Metronidazole | 12 | $210 | $17 |
2022: 8 drugs
| Estradiol | 104 | $8,420 | $81 |
| Premarin | 17 | $7,444 | $438 |
| Progesterone | 28 | $2,483 | $89 |
| Clobetasol Propionate | 29 | $701 | $24 |
| Acyclovir | 13 | $685 | $53 |
| Nystatin-Triamcinolone | 17 | $564 | $33 |
| Valacyclovir | 15 | $545 | $36 |
| Fluconazole | 17 | $121 | $7 |
2021: 1 drug
| Estradiol | 11 | $1,309 | $119 |
2020: 2 drugs
| Ibuprofen | 15 | $120 | $8 |
| Hydrocodone-Acetaminophen | 16 | $99 | $6 |
2019: 3 drugs
| Megestrol Acetate | 13 | $1,091 | $84 |
| Hydrocodone-Acetaminophen | 28 | $200 | $7 |
| Ibuprofen | 12 | $73 | $6 |
2018: 3 drugs
| Megestrol Acetate | 14 | $487 | $35 |
| Hydrocodone-Acetaminophen | 21 | $156 | $7 |
| Ibuprofen | 20 | $104 | $5 |
2017: 4 drugs
| Hydrocodone-Acetaminophen | 22 | $221 | $10 |
| Dexamethasone | 13 | $108 | $8 |
| Ibuprofen | 18 | $96 | $5 |
| Lorazepam | 11 | $63 | $6 |
Money from drug and device companies
$75 in 2025
| 2025 | 2 | 3 | None | $75 |
| 2024 | 7 | 10 | None | $262 |
| 2023 | 7 | 24 | None | $470 |
| 2022 | 7 | 9 | None | $161 |
| 2021 | 6 | 18 | None | $313 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Liletta | $50 | 2 payments
|
| Hologic Sales and Service | Aptima | $25 | 1 payment
|
See all 3 published payments
| Hologic Sales and Service | Meals · 2025-12-16 | Aptima | $25 |
| Abbvie | Meals · 2025-10-07 | Liletta | $25 |
| Abbvie | Meals · 2025-04-09 | Liletta | $25 |
See earlier years (2024, 2023, 2022, 2021)
2024: $262
| Shield Therapeutics | Accrufer | $84 | 1 payment
|
| Astellas Pharma US | Veozah | $75 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kyleena | $26 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $25 | 1 payment
|
| Abbvie | Liletta | $23 | 1 payment
|
| Biogen | Zurzuvae | $17 | 1 payment
|
| Mayne Pharma Commercial | None | $13 | 2 payments
|
2023: $470
| Abbvie | Orilissa | $270 | 13 payments
|
| Pfizer | Comirnaty | $66 | 4 payments
|
| Mayne Pharma Commercial | None | $59 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Mirena | $30 | 1 payment
|
| Astellas Pharma US | Veozah | $17 | 1 payment
|
| CooperSurgical | Paragard T 380a | $15 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $14 | 1 payment
|
2022: $161
| Abbvie | Liletta | $60 | 3 payments
|
| Myovant Sciences | Myfembree | $21 | 1 payment
|
| TherapeuticsMD | Annovera | $19 | 1 payment
|
| Pfizer | Premarin | $18 | 1 payment
|
| CooperSurgical | Paragard | $16 | 1 payment
|
| Organon | Nexplanon | $14 | 1 payment
|
| Avion Pharmaceuticals | Balcoltra | $13 | 1 payment
|
2021: $313
| AbbVie | Oriahnn | $124 | 7 payments
|
| TherapeuticsMD | Annovera | $56 | 3 payments
|
| Merck Sharp & Dohme | Nexplanon | $36 | 2 payments
|
| Evofem Biosciences | Phexxi | $36 | 2 payments
|
| Daiichi Sankyo | Injectafer | $32 | 2 payments
|
| Organon | Nexplanon | $29 | 2 payments
|
Professional record
- NPI
- 1821443235
- Licence
- CA 95016498
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- IN 201357820
- Taxonomy
- Federal specialty code 363LW0102X (363LW0102X)
- Mailing address
- 2500 E Palm Canyon Dr Apt 28, Palm Springs, CA, 92264
- NPI first listed
- 2016-05-04
- NPI last updated
- 2024-11-25
- NPI record certified
- 2024-11-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306